SYMPHONIX Trademark

Trademark Overview


On Friday, December 11, 1998, a trademark application was filed for SYMPHONIX with the United States Patent and Trademark Office. The USPTO has given the SYMPHONIX trademark a serial number of 75603608. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, June 29, 2002. This trademark is owned by DuPont Pharmaceuticals Company. The SYMPHONIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging

General Information


Serial Number75603608
Word MarkSYMPHONIX
Filing DateFriday, December 11, 1998
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, June 29, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 5, 1999

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 5, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Pharma Company
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Party NameDuPont Pharmaceuticals Company
Party Type20 - Owner at Publication
Legal Entity Type02 - Partnership
AddressWilminton, DE 19805

Party NameDuPont Pharmaceuticals Company
Party Type10 - Original Applicant
Legal Entity Type02 - Partnership
AddressWilminton, DE 19805

Trademark Events


Event DateEvent Description
Wednesday, February 19, 2003ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 10, 2002EXTENSION 4 GRANTED
Friday, December 28, 2001EXTENSION 4 FILED
Tuesday, September 18, 2001EXTENSION 3 GRANTED
Thursday, June 28, 2001EXTENSION 3 FILED
Tuesday, April 10, 2001EXTENSION 2 GRANTED
Thursday, December 28, 2000EXTENSION 2 FILED
Thursday, October 5, 2000EXTENSION 1 GRANTED
Tuesday, June 20, 2000EXTENSION 1 FILED
Thursday, July 18, 2002PETITION TO REVIVE-GRANTED
Monday, April 8, 2002PETITION TO REVIVE-RECEIVED
Thursday, February 7, 2002PETITION TO REVIVE-DENIED
Wednesday, June 6, 2001INCOMPLETE PETITION NOTICE MAILED
Wednesday, October 25, 2000PETITION TO REVIVE-RECEIVED
Tuesday, August 29, 2000ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 28, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 1999PUBLISHED FOR OPPOSITION
Friday, September 3, 1999NOTICE OF PUBLICATION
Friday, June 18, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 17, 1999ASSIGNED TO EXAMINER